Next Article in Journal
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study
Next Article in Special Issue
Oxidative Stress Correlates with More Aggressive Features in Thyroid Cancer
Previous Article in Journal
Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy
Previous Article in Special Issue
Optimization of the Management of Category III Thyroid Nodules Using Repeat FNA and TIRADS
 
 
Article

Article Versions Notes

Cancers 2022, 14(22), 5521; https://doi.org/10.3390/cancers14225521
Action Date Notes Link
article xml file uploaded 10 November 2022 09:28 CET Original file -
article xml uploaded. 10 November 2022 09:28 CET Update -
article pdf uploaded. 10 November 2022 09:28 CET Version of Record https://www.mdpi.com/2072-6694/14/22/5521/pdf-vor
article html file updated 10 November 2022 09:30 CET Original file -
article xml file uploaded 11 November 2022 08:05 CET Update -
article xml uploaded. 11 November 2022 08:05 CET Update https://www.mdpi.com/2072-6694/14/22/5521/xml
article pdf uploaded. 11 November 2022 08:05 CET Updated version of record https://www.mdpi.com/2072-6694/14/22/5521/pdf
article html file updated 11 November 2022 08:07 CET Update -
article html file updated 11 November 2022 08:07 CET Update -
article html file updated 28 February 2023 22:20 CET Update -
article html file updated 2 March 2023 22:16 CET Update https://www.mdpi.com/2072-6694/14/22/5521/html
Back to TopTop